Express Scripts (NASDAQ:ESRX) was upgraded by equities researchers at TheStreet from a “c+” rating to a “b-” rating in a report released on Monday.

Several other analysts have also weighed in on ESRX. Morgan Stanley boosted their price objective on Express Scripts from $52.00 to $57.00 and gave the company an “underweight” rating in a report on Thursday, August 10th. Jefferies Group set a $72.00 price objective on Express Scripts and gave the company a “buy” rating in a report on Tuesday, August 29th. Robert W. Baird reissued a “hold” rating and issued a $56.00 price objective on shares of Express Scripts in a report on Friday, September 1st. ValuEngine lowered Express Scripts from a “buy” rating to a “hold” rating in a report on Friday, September 1st. Finally, Royal Bank Of Canada started coverage on Express Scripts in a report on Tuesday, September 19th. They issued a “sector perform” rating and a $68.00 price objective for the company. Six equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $70.67.

Shares of Express Scripts (NASDAQ ESRX) traded up $0.73 during trading on Monday, reaching $68.57. The company had a trading volume of 3,737,241 shares, compared to its average volume of 4,119,528. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.61 and a current ratio of 0.73. The company has a market capitalization of $38,603.98, a price-to-earnings ratio of 9.96, a P/E/G ratio of 1.01 and a beta of 0.88. Express Scripts has a 1 year low of $55.80 and a 1 year high of $76.38.

Express Scripts (NASDAQ:ESRX) last announced its quarterly earnings data on Tuesday, October 24th. The company reported $1.90 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $1.90. The firm had revenue of $24.68 billion during the quarter, compared to analyst estimates of $25.68 billion. Express Scripts had a return on equity of 25.46% and a net margin of 3.64%. Express Scripts’s quarterly revenue was down 2.9% on a year-over-year basis. During the same period in the previous year, the company earned $1.74 earnings per share. equities analysts anticipate that Express Scripts will post 7.01 EPS for the current year.

In other Express Scripts news, Director Woodrow A. Myers, Jr. sold 3,900 shares of Express Scripts stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $63.93, for a total value of $249,327.00. Following the completion of the transaction, the director now directly owns 11,500 shares in the company, valued at $735,195. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Timothy C. Wentworth acquired 8,000 shares of Express Scripts stock in a transaction dated Tuesday, October 31st. The shares were acquired at an average price of $61.13 per share, with a total value of $489,040.00. Following the completion of the transaction, the chief executive officer now owns 98,628 shares of the company’s stock, valued at approximately $6,029,129.64. The disclosure for this purchase can be found here. Over the last 90 days, insiders sold 5,121 shares of company stock valued at $325,920. 0.68% of the stock is currently owned by insiders.

Several hedge funds and other institutional investors have recently modified their holdings of the company. Dodge & Cox boosted its position in shares of Express Scripts by 25.7% during the second quarter. Dodge & Cox now owns 36,188,517 shares of the company’s stock worth $2,310,275,000 after buying an additional 7,388,021 shares during the period. Macquarie Group Ltd. boosted its position in shares of Express Scripts by 8.4% during the second quarter. Macquarie Group Ltd. now owns 11,880,919 shares of the company’s stock worth $758,480,000 after buying an additional 922,406 shares during the period. Northern Trust Corp boosted its position in shares of Express Scripts by 12.2% during the second quarter. Northern Trust Corp now owns 11,068,777 shares of the company’s stock worth $706,629,000 after buying an additional 1,206,980 shares during the period. Veritas Asset Management LLP boosted its position in shares of Express Scripts by 5.6% during the third quarter. Veritas Asset Management LLP now owns 8,652,910 shares of the company’s stock worth $547,902,000 after buying an additional 460,338 shares during the period. Finally, Nordea Investment Management AB boosted its position in shares of Express Scripts by 2.6% during the third quarter. Nordea Investment Management AB now owns 7,304,973 shares of the company’s stock worth $462,551,000 after buying an additional 188,528 shares during the period. Institutional investors and hedge funds own 88.44% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Express Scripts (ESRX) Upgraded at TheStreet” was originally reported by American Banking News and is owned by of American Banking News. If you are accessing this article on another website, it was illegally stolen and republished in violation of U.S. and international copyright law. The legal version of this article can be viewed at https://www.americanbankingnews.com/2017/12/06/express-scripts-esrx-upgraded-at-thestreet.html.

Express Scripts Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Analyst Recommendations for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.